Pharmacists in Palm Beach, FL Accepting Medicare
10 Pharmacists found. Showing 1 - 10
 Allen Anthony Jr. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Bradley Pl, Palm Beach, FL 33480 Phone: 561-832-1978 |
 Sandra Yassa Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Bradley Pl, Palm Beach, FL 33480 Phone: 561-832-1978 |
Mr. Eric Howard Shawe Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 151 N County Rd, Palm Beach, FL 33480 Phone: 561-832-4443 Fax: 561-832-6502 |
Marcus Javier Silio, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Bradley Pl, Palm Beach, FL 33480 Phone: 561-832-1978 |
Lori Ann Johnson, PHARMD Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 2000 S Ocean Blvd, Palm Beach, FL 33480 Phone: 561-737-7733 |
Ildiko Sipos Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 235 Peruvian Ave Ste 3, Palm Beach, FL 33480 Phone: 561-650-0236 Fax: 561-650-0237 |
Mipal Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 235 S County Rd, Palm Beach, FL 33480 Phone: 561-655-7687 Fax: 561-832-1240 |
Dr. Luis Rodriguez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Bradley Pl, Palm Beach, FL 33480 Phone: 561-832-1978 |
Kurt Kosek Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Bradley Pl, Palm Beach, FL 33480 Phone: 561-655-4120 |
Dipti Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 Sunrise Ave, Palm Beach, FL 33480 Phone: 561-659-6713 Fax: 877-222-8521 |
News Archive
XenoPort initiates XP23829 Phase 1 study in healthy adults
XenoPort, Inc. announced today that the first subjects have been dosed in a Phase 1, randomized, double-blind, two-period crossover, food effect comparison study of XP23829 in healthy adults. The trial is designed to assess the pharmacokinetics, safety and tolerability of a single dose of XP23829 administered in both fasted and fed conditions.
Experts discuss treatment as prevention at USAID-, World Bank-sponsored debate
In this post in the Center for Global Development's "Global Health Policy" blog, Amanda Glassman, director of Global Health Policy and a research fellow at the center, reports on last week's USAID- and World Bank-sponsored debate on treatment as prevention, "where debaters were asked to support or oppose the proposition that countries should spend the majority of flat or declining HIV prevention budgets on 'treatment as prevention,' building off the results of the HPTN 052 study which found a relative reduction of 89 percent in the total number of HIV-1 transmissions resulting from the early initiation of antiretroviral therapy.
Timely treatment with Berinert provides faster symptom relief for HAE patients
CSL Behring announced today that treatment with Berinert, C1 Esterase Inhibitor (Human) within six hours of the onset of an acute hereditary angioedema (HAE) attack provides faster symptom relief than later treatment, according to data presented at the 2012 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.
Hand sanitizers provide key benefits when properly used
With cases of intentional misuse of alcohol-based hand sanitizers being widely reported, the American Cleaning Institute (ACI, formerly The Soap and Detergent Association) offered reminders that the products provide key benefits when properly used.
Research shows dramatically rising ED visits related to alcohol
New research shows dramatically rising visits to emergency departments (ED) related to alcohol, especially for women, with a 175% increase in alcohol-related visits from young people aged 25 to 29.
› Verified 7 days ago
Pharmacists
Dentists
Counselors
Clinical Social Workers
Occupational Therapists
Psychologists